Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer'…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark approval for its Elecsys® Apolipoprotein E4 ...

Protein sequencing advance offers new insights into life's foundations

Proteins, one of the smallest building blocks of life on Earth, hold promise for answering some of biology's biggest ...